Patients With HF Report Worse HRQOL Than Those With Cancer

Patients with heart failure (HF) experience worse health-related quality of life (HRQOL) than patients undergoing cancer treatment, according to a pooled analysis of Medicare Health Outcomes Survey data presented at AHA 2023 and simultaneously published in JACC: Heart Failure.

NCDR Study: Is DAPT a Safe Alternative to OAC Post LAAO With Watchman FLX?

Dual antiplatelet therapy (DAPT) was found to have a similar safety profile to oral anticoagulation (OAC) with aspirin after left atrial appendage occlusion (LAAO) with the Watchman FLX, according to a study being presented at AHA 2023 and simultaneously published in JACC: Cardiovascular Interventions.

What Contributes to Worse Outcomes For Women vs. Men With AMI-CS or HF-CS?

Women with heart failure-related cardiogenic shock (HF-CS) had more vascular complications and worse outcomes than men with HF-CS and more studies are needed to advance therapies, decrease complications and improve outcomes for women with CS, according to a working group report being presented at AHA 2023 and simultaneously published in JACC: Heart Failure.

ISCHEMIA: Impact of Early PCI or CABG?

Early revascularization by PCI or CABG in patients with stable coronary artery disease was associated with higher early risks of cardiovascular events, but lower long-term risks, compared with a conservative strategy of initial medical therapy, according to findings from ISCHEMIA presented at AHA 2023 and simultaneously published in JACC. Researchers noted that early risks were greatest following CABG, due to protocol-defined procedural myocardial infarctions (MIs).

Cardio-Obstetrics Focus of JACC: Case Reports Special Issue

Visit JACC.org/CaseReports to read the special issue focusing on maternal health and cardio-obstetrics.

JACC Expert Panel Explores Barriers in Research in Critical Care Cardiology

Although cardiac intensive care units (CICU) have evolved substantially in terms of the patient population, comorbidities and diagnoses, there has been a lag in the generation of high-quality evidence to manage these critically ill patients, according to a JACC Expert Panel article published in JACC.

Eliminating Disparities in PAD Requires Interventions in Education, Access and Health Policy

Disparities by sex, race, socioeconomic status and geography exist in the diagnosis, treatment and outcomes for patients with lower extremity peripheral artery disease (PAD), and eliminating these inequities will require improvements in education, access to care and health policy, according to a JACC Scientific Statement.